Intestinal Obstruction Completed Phase 2 Trials for Octreotide (DB00104)

Back to Intestinal Obstruction

Also known as: Obstruction Bowel / Bowel Obstruction / Other intestinal obstruction / Unspecified intestinal obstruction / Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction / Obstruction intestinal / Intestinal obstruction (disorder) / Intestinal obstruction NOS

Indication	Status	Phase
DBCOND0031423 (Intestinal Obstruction)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00332696	Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis	Treatment	Methylprednisolone (DB00959) Octreotide (DB00104)